Mesoblast Limited

305 articles about Mesoblast Limited

• Mesoblast Limited Receives Clearance to Begin First European Trial of Allogeneic or 'Off-The-Shelf' Stem Cell Treatment for Heart Attacks

  9/6/2011

• Mesoblast Limited in Position of Considerable Strength

  8/25/2011

• First Minimally-Invasive Procedure Performed in Mesoblast Limited's Phase 2 Stem Cell Trial for Lumbar Disc Repair

  8/23/2011

• Mesoblast Limited Heart Failure Trial Selected for Presentation in Special Session of American Heart Association Annual Conference Melbourne, Australia on 15 August 2011

  8/15/2011

• Mesoblast Limited Receives FDA Clearance for Phase 3 Bone Marrow Transplant Trial

  7/7/2011

• FDA Clears Mesoblast Limited Phase 2 Trial to Treat Degenerative Disc Disease

  6/29/2011

• Mesoblast Limited Key Product Franchises Featured at Nomura Asia Equity Forum

  6/14/2011

• Mesoblast Limited Revascor Increases Blood Supply to Damaged Heart Muscle

  6/9/2011

• Mesoblast Limited to Present at Goldman, Sachs & Co. 32nd Annual Global Healthcare Conference

  6/2/2011

• Mesoblast Limited Key Patents Granted In United States Strengthen Commercial Rights And Broaden Clinical Indications

  5/24/2011

• Mesoblast Limited Included In Standard And Poor/ASX 200 Index

  4/18/2011

• Mesoblast Limited Update On Valeant Pharmaceuticals International Proposal To Cephalon, Inc.

  4/7/2011

• Mesoblast Limited Statement on Valeant Pharmaceuticals International Proposal to Cephalon, Inc.

  3/31/2011

• Mesoblast Limited CEO Named BioSpectrum Asia Person Of The Year 2011

  3/17/2011

• Mesoblast Limited Release Half Year Financial Report To 31 Dec 2010

  2/28/2011

• Cephalon, Inc. Buys Stake in Regenerative Medicine Firm Mesoblast Limited

  2/14/2011

• Interim Results From Mesoblast Limited's Phase 2 Heart Failure Trial Shows 'Off-The-Shelf' Proprietary Adult Stem Cell Product Revascor™ Reduces Cardiac Events, Mortality, and Hospitalization

  1/10/2011

• Cephalon, Inc. Buys Mesoblast Limited Stake, Drug Rights in Potential $2 Billion Deal

  12/8/2010

• Mesoblast Limited Chairman Address at 2010 Annual General Meeting

  11/29/2010

• Mesoblast Limited Clear To Proceed With Angioblast Systems Acquisition

  11/19/2010